EcoDrugPlus

Ensembl ID : ENSACLG00000001226
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSACLG00000013472
Gene Symbol: -
Cross references: -
177 Possible Orthologues:

Ensembl ID : ENSACLG00000014098
Gene Symbol: -
Cross references: -
181 Possible Orthologues:

Ensembl ID : ENSACLG00000018682
Gene Symbol: -
Cross references: -
184 Possible Orthologues:

Ensembl ID : ENSACLG00000019638
Gene Symbol: -
Cross references: -
183 Possible Orthologues:

Ensembl ID : ENSACLG00000023531
Gene Symbol: -
Cross references: -
186 Possible Orthologues:

Ensembl ID : ENSACLG00000003149
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSACLG00000006812
Gene Symbol: -
Cross references: -
180 Possible Orthologues:

Ensembl ID : ENSACLG00000007130
Gene Symbol: -
Cross references: -
185 Possible Orthologues:

Ensembl ID : ENSACLG00000007527
Gene Symbol: -
Cross references: -
179 Possible Orthologues:

Ensembl ID : ENSACLG00000010527
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSACLG00000020527
Gene Symbol: -
Cross references: -
180 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).